CooperCompanies Announces First Quarter 2025 Results

About this update from The Cooper Companies, Inc.

[{"type":"text","content":"SAN RAMON, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal first quarter ended January 31, 2025. Revenue increased 4% year-over-year to $964.7 million. CooperVision (CVI) revenue up 4% to $646.1 million, and CooperSurgical (CSI) revenue up 3% to $318.6 million.GAAP diluted earnings per share (EPS) of $0.52, up $0.11 from last year's first quarter.Non-GAAP diluted EPS of $0.92, up $0.07 from last year's first quarter. See \"Reconciliation of Selected GAAP Results to Non-GAAP Results\" below. Commenting on the results, Al White, Cooper's President and CEO said, \"We started the year on a positive note meeting our revenue expectations and exceeding our operational targets. Moving forward, we remain confident in our ability to deliver strong growth and operational excellence, and this is reflected in our guidance.\" First Quarter Operating Results Revenue of $964.7 million, up 4% from last year’s first quarter, up 5% in constant currency, up 5% organically.Gross margin of 68% compared with 67% in last year’s first quarter driven by efficiency gains and mix. On a non-GAAP basis, gross margin was 69%, up from 67% last year.Operating margin of 19% compared with 16% in last year’s first quarter driven by stronger gross margins and targeted G&A expense leverage. On a non-GAAP basis, operating margin was 25%, up from 24% last year.Interest expense of $26.0 million compared with $29.9 million in last year's first quarter driven by lower interest rates and lower average debt. On a non-GAAP basis, interest expense was $25.3 million, down from $28.6 million.Cash provided by operations of $190.6 million offset by capital expenditures of $89.4 million resulted in free cash flow of $101.2 million. First Quarter CooperVision (CVI) Revenue Revenue of $646.1 million, up 4% from last year’s first quarter, up 6% in constant currency, up 6% organically.Revenue by category: % change y/y (In millions) Reported Currency Impact Constant Currency Acquisitions and Divestitures Organic 1Q25 Toric and multifocal$319.4 7% 3% 10% —% 10% Sphere, other 326.7 1% 2% 3% —% 3% Total$646.1 4% 2% 6% —% 6% Revenue by geography: % change y/y (In millions) Reported Currency Impact Constant Currency Acquisitions and Divestitures Organic 1Q25 Americas$270.9 7%...

More updates from The Cooper Companies, Inc.